1. Upadacitinib combined with topical corticosteroids reduced Eczema Area and Severity Index (EASI) and Investigator’s Global Assessment for atopic dermatitis ...
1. The proportion of patients with EASI ≥75% was significantly greater in the upadacitinib 30 mg and 15 mg groups ...
1. Individuals diagnosed with atopic dermatitis (AD) as children were at elevated risk of not attaining lower and upper secondary ...
1. In this study, nemolizumab with topical agents and oral antihistamines when compared to topical agents and oral antihistamines alone ...
1. In treatment-resistant childhood atopic dermatitis, omalizumab significantly reduced the severity of dermatitis and improved quality of life compared to ...
PD-1 blockade in advanced adrenocortical carcinoma 1. Pembrolizumab may provide clinically meaningful anti-tumor activity in the setting of adrenocortical carcinoma, ...
Atopic dermatitis, a common disorder in the pediatric population, is associated with pruritus that is often worse at night and, ...
1. The results of this study suggested that the prevalence of atopic dermatitis increased with age among a U.K. adult ...
1. The majority of patients using pimecrolimus cream (PIM, 52.6%) or topical corticosteroids (TCS, 50.5%) for the treatment of mild ...
In this section, we highlight the key high-impact studies, updates, and analyses published in medicine during the past week. Randomized ...
